219 Managing Beef Cattle Growth Amidst a Global Pandemic: Lessons Learned from 2020 and Strategies for the Future

The coronavirus disease-19 related events of 2020 had severe detrimental effects on meat animal production in the United State. Due to harvest facility slowdowns and shutdowns, many market animals, including beef cattle, were on feed greater than 60 d past their optimal endpoint. These dramatic changes caused many changes in feeding and growth technologies management. The two major growth enhancing compounds used in feedlot cattle production are steroidal implants (IMP) and β-adrenergic agonists (β-AA). Implementation of β-AA during the pandemic was extremely difficult due to the lack of knowledge on exact shipping dates. The β-AA are fed the last 28 to 42 d on feed. Ractopamine was approved for cattle with essential a 12-h withdrawal. Many questions arose about the maximum length of withdrawal on ractopamine before losing any of the added growth response in both the live animal and carcass. Many feedlot operators relied on IMP administration to achieve added growth response in cattle held for longer days on feed. With zero-day withdrawal on implants, it was a cost-effective means to hold cattle in an efficient manner. Many producers simply could not manage β-AA feeding during the pandemic period and used other management technologies to enhance growth and efficiency during the end of the feeding period.